Abstract
Background
There is a need for systematic reviews and meta-analyses to synthesize the epidemiology, and the riskfactors for hepatitis C virus (HCV) among HIV-coinfected and HIV negative men who have sex with men (MSM).
Methods
A meta-analysis of 28 studies was carried out by pooling HCV incidence data of HIV-coinfected and HIV negative MSM. Differences in incidence outcome depending on the prospective or retrospective nature of the individual studies were investigated.
Results
The pooled incidence of HCV in MSM was 6.3 per 1000 person-years (95% CI 5.0–7.5). The overall estimated incidence was 19-fold higher in HIV positive compared to HIV negative MSM living in resource-rich countries. This result was confirmed when the analysis was restricted to high-quality studies. Factors associated with an increased risk for incident HCV included behavioural factors (sexual risk behaviour and recreational drug use) as well as biological characteristics (HIV coinfection and a recent history of syphilis).
Conclusion
In conclusion, incident HCV predominantly affects HIV positive MSM. The incidence rate varied largely between studies, factors such as study design might play an important role.
Similar content being viewed by others
References
Sanchez C, Plaza Z, Vispo E, de Mendoza C, Barreiro P, Fernandez-Montero JV, et al. Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain. Liver Int. 2013;33:1357–62.
Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002;36:S93–8.
Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26:171–84.
Van De Laar TJW, Van Der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis. 2007;196:230–8.
Giraudon I, Ruf M, Maguire H, Charlett A, Ncube F, Turner J, et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002–2006: is this an outbreak? Sex Transm Infect. 2008;84:111–5.
Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001–2009. Eurosurveillance. 2010;15:1–8.
Urbanus AT, Van De Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009;23:F1–7.
Wandeler G, Gsponer T, Bregenzer A, Gunthard HF, Clerc O, Calmy A, et al. Hepatitis C virus infections in the swiss HIV cohort study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55:1408–16.
Stall R, Wei C, Raymond HF, McFarland W. Do rates of unprotected anal intercourse among HIV-positive MSM present a risk for hepatitis C transmission? Sexually Transmitted Infections. 2011;87:439–41.
van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136:1609–17.
Van De Laar TJW, Matthews GV, Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS. 2010;24:1799–812.
Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology (Baltimore, Md). 2010;52:1497–505.
Witt MD, Seaberg EC, Darilay A, Young S, Badri S, Rinaldo CR, et al. Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984–2011. Clin Infect Dis. 2013;57:77–84.
Jin F, Prestage GP, Matthews G, Zablotska I, Rawstorne P, Kippax SC, et al. Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia. Sex Transm Infect. 2010;86:25–8.
Richardson D, Fisher M, Sabin CA. Sexual transmission of hepatitis C in MSM may not be confined to those with HIV infection. J Infect Dis. 2008;197:1213–4.
Alary M, Joly JR, Vincelette J, Lavoie R, Turmel B, Remis RS. Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men. Am J Public Health. 2005;95:502–5.
de Ledinghen V, Barreiro P, Foucher J, Labarga P, Castera L, Vispo ME, et al. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat. 2008;15:427–33.
Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the US. Clin Infect Dis. 2012;55:S10–5.
Kouyos RD, Rauch A, Braun DL, Yang WL, Boni J, Yerly S, et al. Higher risk of incident hepatitis c virus coinfection among men who have sex with men, in whom the hiv genetic bottleneck at transmission was wide. J Infect Dis. 2014;210:1555–61.
El-Hayek C, Doyle JS, Cuevas M, Lim M, Fairley CK, Leslie DE, et al. New Hepatitis C infection and re-infection among HIV co-infected men in Melbourne, Australia. Hepatol Int. 2014;8:S183–4.
Garg S, Taylor LE, Grasso C, Mayer KH. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a boston community health center. Clin Infect Dis. 2013;56:1480–7.
Brook G, McSorley J, Shaw A. Retrospective study of the effect of enhanced systematic sexually transmitted infection screening, facilitated by the use of electronic patient records, in an HIV-infected cohort. HIV Med. 2013;14:347–53.
Apers L, Koole O, Bottieau E, Vandenbruaene M, Ophoff D, Van Esbroeck M, et al. Incidence of HCV and sexually transmitted diseases among HIV positive MSM in antwerp, Belgium, 2001–2011. Acta Clin Belg. 2013;68:421–6.
Taylor LE, Delong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, et al. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. AIDS Patient Care STDs. 2011;25:571–7.
Barfod TS, Omland LH, Katzenstein TL. Incidence and characteristics of sexually transmitted acute hepatitis C virus infection among HIV-positive men who have sex with men in Copenhagen, Denmark during four years (2006–2009): a retrospective cohort study. Scand J Infect Dis. 2011;43:145–8.
Vanhommerig JW, Stolte IG, Lambers FAE, Geskus RB, Van De Laar TJW, Bruisten SM, et al. Stabilizing incidence of hepatitis c virus infection among men who have sex with men in Amsterdam. J Acquir Immune Defic Syndr. 2014;66:e111–5.
Martin NK, Thornton A, Hickman M, Sabin C, Nelson M, Cooke GS, et al. Can hepatitis C virus (HCV) direct-acting antiviral treatment as prevention reverse the HCV Epidemic among men who have sex with men in the UK? Epidemiological and modeling insights. Clin Infect Dis. 2016;62:1072–80.
Hullegie SJ, van den Berk GE, Leyten EM, Arends JE, Lauw FN, van der Meer JT, et al. Acute hepatitis C in The Netherlands: characteristics of the epidemic in 2014. Clin Microbiol Infect. 2016;22:209.e1–3.
van Rooijen M, Heijman T, de Vrieze N, Urbanus A, Speksnijder A, van Leeuwen P, et al. Earlier detection of hepatitis C virus infection through routine hepatitis C virus antibody screening of human immunodeficiency virus-positive men who have sex with men attending a sexually transmitted infection outpatient clinic: a longitudinal study. Sex Transm Dis. 2016;43:560–5.
Neukam K, Viciana P, Ojeda-Burgos G, Delgado-Fernandez M, Rios MJ, Macias J, et al. No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000 to 2014. BMC Infect Dis. 2016;16:489.
Burchell AN, Gardner SL, Mazzulli T, Manno M, Raboud J, Allen VG, et al. Hepatitis C virus seroconversion among Hiv-positive men who have sex with men with no history of injection drug use: results from a clinical Hiv cohort. Can J Infect Dis Med Microbiol. 2015;26:17–22.
Sobrino-Vegas P, Monge Corella S, Serrano-Villar S, Gutierrez F, Blanco JR, Santos I, et al. Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004–2011: increasing rates of HCV diagnosis but not of HCV seroconversions. PLoS One. 2014;9(12):e116226.
Daskalopoulou M, Rodger A, Thornton A, Phillips A, Sherr L, Gilson R, et al. Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the UK: results from the ASTRA study. J Int AIDS Soc. 2014;17:93–4.
Sun HY, Chang SY, Yang ZY, Lu CL, Wu H, Yeh CC, et al. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol. 2012;50:781–7.
Gamage DG, Read TR, Bradshaw CS, Hocking JS, Howley K, Chen MY, et al. Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study. BMC Infect Dis. 2011;11:39.
Turner JM, Rider AT, Imrie J, Copas AJ, Edwards SG, Dodds JP, et al. Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men. Sex Transm Infect. 2006;82:298–300.
Rauch A, Rickenbach M, Weber R, Hirschel B, Tarr PE, Bucher HC, et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV cohort study. Clin Infect Dis. 2005;41:395–402.
Breskin A, Drobnik A, Pathela P, Chan C, Braunstein S, Bornschlegel K, et al. Factors associated with hepatitis C infection among HIV-infected men who have sex with men with no reported injection drug use in New York city, 2000–2010. Sex Transm Dis. 2015;42:382–6.
Jansen K, Thamm M, Bock CT, Scheufele R, Kucherer C, Muenstermann D, et al. High Prevalence and high incidence of coinfection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany. PLoS One. 2015;10:e0142515.
Yaphe S, Bozinoff N, Kyle R, Shivkumar S, Pai NP, Klein M. Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review. Sex Transm Infect. 2012;88:558–64.
Hagan H, Neurer J, Jordan AE, Des Jarlais DC, Wu J, Dombrowski K, et al. Hepatitis C virus incidence among HIV+ men who have sex with men: the role of non-injection drug use. Drug Alcohol Depend. 2015;146:e133.
Urbanus AT, Van De Laar TJW, Geskus R, Vanhommerig JW, Van Rooijen MS, Schinkel J, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995–2010. AIDS. 2014;28:781–90.
Briat A, Dulioust E, Galimand J, Fontaine H, Chaix ML, Letur-Konirsch H, et al. Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin. AIDS. 2005;19:1827–35.
Schmidt AJ, Rockstroh JK, Vogel M, An der Heiden M, Baillot A, Krznaric I, et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany—a case-control study. PLoS One. 2011;6(3):e17781.
Vanhommerig JW, Lambers FA, Schinkel J, Geskus RB, Arends JE, van de Laar TJ, et al. Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who Have sex with men: a case–control study. Open Forum Infect Dis. 2015;2:ofv115.
Simmons B, Saleem J, Hill A, Riley RD, Cooke GS. Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis. 2016;62:683–94.
Hagan LM, Wolpe PR, Schinazi RF. Treatment as prevention and cure towards global eradication of hepatitis C virus. Trends Microbiol. 2013;21:625–33.
Pawlotsky JM, Hepatitis C. Virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology. 2016;151:70–86.
Bradshaw D, Matthews G, Danta M. Sexually transmitted hepatitis C infection: the new epidemic in MSM? Curr Opin Infect Dis. 2013;26:66–72.
Acknowledgements
The authors thank Damian Cueni for language editing and Dr. Martina Gosteli for her support in the literature search.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
JSF was a member of the advisory board of Abbvie, Bristol Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dome and has received unrestricted Grants and travel Grants from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dome, Pfizer, Roche, ViiV Healthcare. He is a member of the Swiss Federal Commission for Sexual Health. DLB was supported by the University of Zurich’s Clinical research Priority Program (CRPP) “Viral infectious diseases: Zurich Primary HIV Infection Study”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declared no financial relationships with any organisations that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work.
Additional information
V. Ghisla and A. U. Scherrer contributed equally to this study, as did D. L. Braun and J. S. Fehr.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ghisla, V., Scherrer, A.U., Nicca, D. et al. Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000–2016: a systematic review and meta-analysis. Infection 45, 309–321 (2017). https://doi.org/10.1007/s15010-016-0975-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-016-0975-y